Clinical Trial


A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence.

Trial overview


Early breast cancer

Eligibility criteria

To be considered for this study you must meet the following criteria:

  • 50 years of age or older
  • Have histologically confirmed breast cancer

Study details

This is a randomised study and your participation in this study would be approximately 5 years.

Patients randomized to Arm A will receive standard radiation therapy and adjuvant endocrine therapy (standard of care).

Patients randomized to Arm B will not receive radiation therapy (omission of radiation therapy) and receive adjuvant endocrine therapy only.

You will be required to attend clinic visit approximately every 6 months and be required to complete Quality of life questionnaires throughout the study.

Further information

For further information regarding this clinical trial click here.

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.